Herpes Cure Advocacy is pleased to welcome Dr. David Leib to our Medical Advisory Board. Dr. Leib is the Chair and Professor of Microbiology and Immunology at Dartmouth Geisel SchoolContinueContinue reading “Dr. David Leib Joins Herpes Cure Advocacy Medical Advisory Board”
Category Archives: Advocacy
News from Herpes Cure Advocacy
There is momentum in the field of new herpes diagnostics and therapies. Advocates, experts and patient advocates continue to urge public health stakeholders to advance new vaccines into clinical trialsContinueContinue reading “News from Herpes Cure Advocacy”
The Landscape for Herpes is Changing: Our Impact
Have you been following the transformational changes Herpes Cure Advocacy has initiated in the landscape of herpes?
Herpes Cure Pipeline 3.0 Release
Join the Party Herpes Cure and Treatment News At long last – the Herpes Cure Pipeline 3.0 is (almost) ready for release. To confirm your attendance, please join the waitContinueContinue reading “Herpes Cure Pipeline 3.0 Release”
Key Stakeholders for Herpes Patient Advocacy
USE YOUR VOICE FOR CHANGE How long until a herpes cure? When asking this question – ask yourself, what can I do to help? Want to know when the nextContinueContinue reading “Key Stakeholders for Herpes Patient Advocacy”
How to Advocate the FDA for Accurate Herpes Testing
Why do we need advocacy at the FDA? Because any Herpes Simplex Virus prevention strategy in the US is incomplete without an accurate diagnostic test. There is currently NO FDA-approvedContinueContinue reading “How to Advocate the FDA for Accurate Herpes Testing”
New HSV Advocates: A Starters Guide to Activism
Getting started with Herpes Advocacy Step 1: Get Informed GET INFORMED: Make sure you know the Herpes 101 facts so you can speak to them in your advocacy. Read theContinueContinue reading “New HSV Advocates: A Starters Guide to Activism”
Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients
AiCuris AG, a German biotech company, is currently recruiting for their clinical trial on Pritelivir. Pritelivir is a highly anticipated new treatment for resistant Herpes Simplex Virus infections that cannotContinueContinue reading “Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients”
Call for Herpes Advocates: Rally for a cure with us!
Want to rally for a cure with us? Why isn’t there a herpes cure or even a diagnostic test that works? Why have there been no treatment improvements in 40ContinueContinue reading “Call for Herpes Advocates: Rally for a cure with us!”
National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget
Herpes Cure Advocacy confirms a national strategy and strategic plan for Herpes Simplex Virus Types 1 and 2 in the approved House FY 2022 budget. On page 245, the HouseContinueContinue reading “National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget”